 Laurel Messer
Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Infusion Systems | 49 | 2025 | 447 | 9.190 |
Why?
| | Diabetes Mellitus, Type 1 | 74 | 2025 | 3706 | 7.400 |
Why?
| | Blood Glucose Self-Monitoring | 43 | 2024 | 684 | 5.060 |
Why?
| | Hypoglycemic Agents | 44 | 2025 | 1341 | 4.350 |
Why?
| | Insulin | 47 | 2025 | 2448 | 4.330 |
Why?
| | Diabetes Mellitus | 13 | 2025 | 1068 | 3.670 |
Why?
| | Blood Glucose | 54 | 2024 | 2239 | 3.300 |
Why?
| | Pancreas, Artificial | 14 | 2021 | 98 | 3.270 |
Why?
| | Hypoglycemia | 18 | 2023 | 460 | 2.550 |
Why?
| | Self-Management | 4 | 2022 | 192 | 1.750 |
Why?
| | Biomedical Technology | 3 | 2020 | 50 | 1.320 |
Why?
| | Hyperglycemia | 11 | 2022 | 358 | 1.190 |
Why?
| | Health Plan Implementation | 2 | 2020 | 145 | 1.130 |
Why?
| | Patient Education as Topic | 5 | 2021 | 766 | 0.970 |
Why?
| | Adolescent | 49 | 2024 | 21564 | 0.950 |
Why?
| | Insulin, Regular, Human | 6 | 2023 | 48 | 0.880 |
Why?
| | Technology | 3 | 2023 | 94 | 0.870 |
Why?
| | Patient Compliance | 3 | 2020 | 598 | 0.850 |
Why?
| | Humans | 90 | 2025 | 138651 | 0.810 |
Why?
| | Health Personnel | 4 | 2025 | 732 | 0.780 |
Why?
| | Awareness | 1 | 2023 | 99 | 0.750 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2025 | 2490 | 0.710 |
Why?
| | Mobile Applications | 2 | 2023 | 178 | 0.700 |
Why?
| | Attitude | 2 | 2020 | 259 | 0.660 |
Why?
| | Quality of Life | 6 | 2024 | 2954 | 0.630 |
Why?
| | Patient Dropouts | 1 | 2020 | 62 | 0.620 |
Why?
| | Young Adult | 28 | 2023 | 13305 | 0.610 |
Why?
| | Personal Satisfaction | 2 | 2021 | 214 | 0.610 |
Why?
| | Self Efficacy | 2 | 2021 | 404 | 0.600 |
Why?
| | School Nursing | 1 | 2019 | 34 | 0.590 |
Why?
| | Eczema | 1 | 2018 | 70 | 0.540 |
Why?
| | Patient Reported Outcome Measures | 4 | 2024 | 416 | 0.520 |
Why?
| | School Health Services | 1 | 2019 | 230 | 0.500 |
Why?
| | Child | 33 | 2024 | 21921 | 0.490 |
Why?
| | Infusions, Subcutaneous | 1 | 2016 | 23 | 0.490 |
Why?
| | Adult | 33 | 2024 | 38201 | 0.480 |
Why?
| | Male | 39 | 2024 | 68260 | 0.430 |
Why?
| | Skin | 2 | 2018 | 754 | 0.430 |
Why?
| | Female | 42 | 2024 | 73763 | 0.430 |
Why?
| | Health Behavior | 1 | 2019 | 773 | 0.410 |
Why?
| | Monitoring, Ambulatory | 3 | 2020 | 90 | 0.390 |
Why?
| | Telemedicine | 1 | 2022 | 873 | 0.390 |
Why?
| | Patient Satisfaction | 3 | 2023 | 688 | 0.380 |
Why?
| | Insulin Lispro | 2 | 2022 | 41 | 0.380 |
Why?
| | Insulin Aspart | 2 | 2022 | 29 | 0.380 |
Why?
| | Curriculum | 1 | 2019 | 1009 | 0.380 |
Why?
| | Clinical Competence | 1 | 2019 | 1149 | 0.350 |
Why?
| | Algorithms | 8 | 2024 | 1740 | 0.340 |
Why?
| | Glucose | 5 | 2023 | 1032 | 0.300 |
Why?
| | Insulin-Secreting Cells | 2 | 2023 | 375 | 0.290 |
Why?
| | Skiing | 2 | 2019 | 50 | 0.270 |
Why?
| | Surveys and Questionnaires | 6 | 2023 | 5803 | 0.260 |
Why?
| | Exercise | 6 | 2020 | 2072 | 0.250 |
Why?
| | Meals | 2 | 2018 | 132 | 0.240 |
Why?
| | Bionics | 2 | 2022 | 14 | 0.240 |
Why?
| | Follow-Up Studies | 5 | 2023 | 5112 | 0.240 |
Why?
| | Prospective Studies | 6 | 2023 | 7554 | 0.230 |
Why?
| | Dermatitis, Contact | 1 | 2023 | 18 | 0.210 |
Why?
| | Feasibility Studies | 3 | 2024 | 980 | 0.210 |
Why?
| | Diabetic Ketoacidosis | 2 | 2023 | 202 | 0.200 |
Why?
| | Calibration | 3 | 2019 | 148 | 0.200 |
Why?
| | Smartphone | 1 | 2023 | 88 | 0.190 |
Why?
| | Program Evaluation | 3 | 2021 | 916 | 0.180 |
Why?
| | Retrospective Studies | 5 | 2023 | 15909 | 0.180 |
Why?
| | Adipose Tissue | 2 | 2016 | 643 | 0.180 |
Why?
| | Pancreas | 1 | 2022 | 322 | 0.160 |
Why?
| | Nursing Theory | 1 | 2019 | 11 | 0.160 |
Why?
| | Pilot Projects | 2 | 2019 | 1765 | 0.150 |
Why?
| | Sports | 2 | 2019 | 217 | 0.150 |
Why?
| | Vaginal Smears | 1 | 1999 | 60 | 0.150 |
Why?
| | Activities of Daily Living | 3 | 2017 | 421 | 0.150 |
Why?
| | Models, Educational | 1 | 2019 | 95 | 0.150 |
Why?
| | Lichen Sclerosus et Atrophicus | 1 | 2018 | 4 | 0.150 |
Why?
| | Genital Diseases, Male | 1 | 2018 | 18 | 0.140 |
Why?
| | Genital Diseases, Female | 1 | 2018 | 31 | 0.140 |
Why?
| | Wireless Technology | 1 | 2017 | 15 | 0.140 |
Why?
| | Intention | 1 | 2019 | 173 | 0.140 |
Why?
| | Delphi Technique | 1 | 2019 | 289 | 0.130 |
Why?
| | Middle Aged | 10 | 2024 | 33604 | 0.130 |
Why?
| | Scleroderma, Systemic | 1 | 2018 | 122 | 0.130 |
Why?
| | Adolescent Nutritional Physiological Phenomena | 1 | 2017 | 29 | 0.130 |
Why?
| | Costs and Cost Analysis | 1 | 2017 | 222 | 0.130 |
Why?
| | Emotions | 2 | 2023 | 568 | 0.130 |
Why?
| | Clinical Alarms | 1 | 2016 | 10 | 0.130 |
Why?
| | Pediatrics | 1 | 2024 | 1078 | 0.130 |
Why?
| | Subcutaneous Tissue | 1 | 2016 | 25 | 0.120 |
Why?
| | Healthcare Disparities | 1 | 2023 | 659 | 0.120 |
Why?
| | Ketones | 1 | 2016 | 48 | 0.120 |
Why?
| | Infusion Pumps, Implantable | 1 | 2016 | 26 | 0.120 |
Why?
| | Consensus | 3 | 2024 | 685 | 0.120 |
Why?
| | Health Education | 1 | 1999 | 357 | 0.120 |
Why?
| | Decision Support Systems, Clinical | 1 | 2020 | 253 | 0.120 |
Why?
| | Self Concept | 1 | 2017 | 260 | 0.120 |
Why?
| | Suicide | 1 | 2023 | 663 | 0.120 |
Why?
| | Child, Preschool | 6 | 2022 | 11158 | 0.120 |
Why?
| | Cost of Illness | 1 | 2017 | 309 | 0.120 |
Why?
| | Quality Improvement | 2 | 2021 | 1213 | 0.110 |
Why?
| | User-Computer Interface | 1 | 2016 | 164 | 0.110 |
Why?
| | Attitude of Health Personnel | 1 | 2023 | 1157 | 0.110 |
Why?
| | Colorado | 4 | 2019 | 4555 | 0.110 |
Why?
| | Anxiety | 2 | 2023 | 1072 | 0.110 |
Why?
| | Adolescent Behavior | 2 | 2017 | 532 | 0.110 |
Why?
| | Fear | 1 | 2017 | 344 | 0.110 |
Why?
| | Interpersonal Relations | 1 | 2017 | 409 | 0.110 |
Why?
| | Sleep Wake Disorders | 1 | 2017 | 301 | 0.110 |
Why?
| | Patient Participation | 1 | 2017 | 428 | 0.110 |
Why?
| | Depression | 1 | 2023 | 1466 | 0.100 |
Why?
| | Indians, North American | 1 | 1999 | 644 | 0.100 |
Why?
| | Acetaminophen | 1 | 2015 | 258 | 0.100 |
Why?
| | C-Peptide | 2 | 2023 | 163 | 0.090 |
Why?
| | Precision Medicine | 1 | 2016 | 424 | 0.090 |
Why?
| | Cohort Studies | 3 | 2017 | 5697 | 0.090 |
Why?
| | Age Factors | 2 | 2016 | 3256 | 0.090 |
Why?
| | Parents | 2 | 2021 | 1421 | 0.090 |
Why?
| | Mass Screening | 1 | 1999 | 1292 | 0.080 |
Why?
| | Terbutaline | 1 | 2010 | 9 | 0.080 |
Why?
| | Registries | 1 | 2019 | 2073 | 0.080 |
Why?
| | Circadian Rhythm | 1 | 2015 | 489 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5520 | 0.080 |
Why?
| | Seasons | 3 | 2019 | 538 | 0.080 |
Why?
| | Sleep | 1 | 2016 | 799 | 0.080 |
Why?
| | Self Care | 2 | 2010 | 387 | 0.080 |
Why?
| | Cross-Over Studies | 3 | 2019 | 556 | 0.080 |
Why?
| | Amyloid | 1 | 2009 | 95 | 0.070 |
Why?
| | Double-Blind Method | 2 | 2023 | 1949 | 0.070 |
Why?
| | Aged | 4 | 2022 | 24024 | 0.070 |
Why?
| | Cold Temperature | 2 | 2019 | 188 | 0.060 |
Why?
| | Eating | 1 | 2009 | 392 | 0.060 |
Why?
| | Age of Onset | 2 | 2022 | 514 | 0.060 |
Why?
| | Teaching | 1 | 2009 | 233 | 0.060 |
Why?
| | Snacks | 2 | 2017 | 23 | 0.060 |
Why?
| | Equipment Failure | 2 | 2016 | 110 | 0.060 |
Why?
| | Hypertrophy | 2 | 2016 | 136 | 0.060 |
Why?
| | Outpatients | 2 | 2021 | 419 | 0.060 |
Why?
| | Consensus Development Conferences as Topic | 1 | 2024 | 33 | 0.050 |
Why?
| | Family | 1 | 2009 | 677 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2019 | 10923 | 0.050 |
Why?
| | Verapamil | 1 | 2023 | 40 | 0.050 |
Why?
| | Area Under Curve | 2 | 2016 | 319 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2023 | 1374 | 0.050 |
Why?
| | North Carolina | 2 | 1999 | 120 | 0.050 |
Why?
| | Self-Injurious Behavior | 1 | 2023 | 136 | 0.040 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2019 | 61 | 0.040 |
Why?
| | Volunteers | 1 | 1999 | 37 | 0.040 |
Why?
| | Health Status | 1 | 2024 | 819 | 0.040 |
Why?
| | Community-Institutional Relations | 1 | 1999 | 101 | 0.040 |
Why?
| | France | 1 | 2018 | 37 | 0.040 |
Why?
| | Societies, Medical | 1 | 2022 | 839 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 2010 | 768 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2019 | 191 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2016 | 1941 | 0.030 |
Why?
| | Virginia | 1 | 2017 | 64 | 0.030 |
Why?
| | Suicidal Ideation | 1 | 2023 | 533 | 0.030 |
Why?
| | Artificial Intelligence | 1 | 2021 | 295 | 0.030 |
Why?
| | Equipment Design | 1 | 2019 | 519 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1518 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2019 | 245 | 0.030 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2017 | 107 | 0.030 |
Why?
| | Body Mass Index | 2 | 2017 | 2349 | 0.030 |
Why?
| | Accelerometry | 1 | 2017 | 109 | 0.030 |
Why?
| | Drug Dosage Calculations | 1 | 2016 | 22 | 0.030 |
Why?
| | Food Preferences | 1 | 2017 | 124 | 0.030 |
Why?
| | Materials Testing | 1 | 2017 | 350 | 0.030 |
Why?
| | United States | 3 | 2017 | 14938 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 562 | 0.030 |
Why?
| | Child Behavior | 1 | 2017 | 249 | 0.030 |
Why?
| | Risk | 1 | 2017 | 893 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2016 | 215 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 205 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1235 | 0.030 |
Why?
| | Patient Care Team | 1 | 2019 | 647 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1323 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3984 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2727 | 0.020 |
Why?
| | Age Distribution | 1 | 2012 | 393 | 0.020 |
Why?
| | Smoking | 1 | 1998 | 1591 | 0.020 |
Why?
| | Glycosuria | 1 | 2009 | 10 | 0.020 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2009 | 48 | 0.020 |
Why?
| | Postprandial Period | 1 | 2009 | 110 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2044 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2009 | 153 | 0.020 |
Why?
| | Hospitalization | 1 | 2017 | 2235 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2007 | 78 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 7677 | 0.020 |
Why?
| | Body Weight | 1 | 2009 | 992 | 0.010 |
Why?
| | Risk Factors | 2 | 2015 | 10252 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 6851 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2007 | 3307 | 0.010 |
Why?
| | Imitative Behavior | 1 | 1998 | 4 | 0.010 |
Why?
| | Socialization | 1 | 1998 | 28 | 0.010 |
Why?
| | Internal-External Control | 1 | 1998 | 77 | 0.010 |
Why?
| | Social Adjustment | 1 | 1998 | 64 | 0.010 |
Why?
| | Infant | 1 | 2012 | 9574 | 0.010 |
Why?
| | Smoking Prevention | 1 | 1998 | 183 | 0.010 |
Why?
| | Peer Group | 1 | 1998 | 243 | 0.010 |
Why?
| | Parenting | 1 | 1998 | 316 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 1998 | 2844 | 0.010 |
Why?
|
|
Messer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|